Four Tips For Harnessing Growth In East Africa
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies may be tempted by the lure of the East African Community, where the discovery of oil and minerals, a growing middle class and the growing need for innovative medicines means the pharmaceutical market is likely to almost double within the next seven years. William Mwatu, chairman of KAPI (Kenya Association of the Pharmaceutical Industry) tells Scrip what companies need to know about how to successfully grow business there.
You may also be interested in...
Early Advice Crucial For Navigating Denmark’s New Appraisal System
Denmark is moving to a QALY based evaluation system for hospital drugs. Despite a more complex process, the change could still mean quicker market access, says the pharmaceutical industry.
What’s Next After 20 Years Of NICE?
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
Profile: Meindert Boysen On What Companies Should Expect From NICE And The Benefits Of Hill Walking
In an exclusive interview with the Pink Sheet, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.
Need a specific report? 1000+ reports available
Buy Reports